Pharmaceutical Industry Reports Rivaroxaban market 点击阅读
  • 评论

Pharmaceutical Industry Reports

Rivaroxaban market

出版日期 / “健康与健身, 科学” / 语言—English / 8页
Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and potentially life-threatening conditions associated with blood coagulation. 更多

“ Pharmaceutical Industry Reports”的其他出版物

查看所有出版物